ZLDPF Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Zealand Pharma A/S - Alpha Spread
Z

Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 136.76 USD 4.55% Market Closed
Market Cap: 9.7B USD
Have any thoughts about
Zealand Pharma A/S?
Write Note

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 154.09 USD with a low forecast of 121.06 USD and a high forecast of 174 USD.

Lowest
Price Target
121.06 USD
11% Downside
Average
Price Target
154.09 USD
13% Upside
Highest
Price Target
174 USD
27% Upside
Zealand Pharma A/S Competitors:
Price Targets
INCY
Incyte Corp
18% Upside
VCYT
Veracyte Inc
4% Upside
ARWR
Arrowhead Pharmaceuticals Inc
124% Upside
XBIT
XBiotech Inc
155% Upside
VICO
Vicore Pharma Holding AB
612% Upside
LYEL
Lyell Immunopharma Inc
204% Upside
096530
Seegene Inc
26% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 3 years is 82%.

8%
Past Growth
82%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
154.09 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 154.09 USD with a low forecast of 121.06 USD and a high forecast of 174 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
82%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is 8%. The projected CAGR for the next 3 years is 82%.

Back to Top